表紙
市場調查報告書

粉末定量噴霧吸入器:醫療設備的開發平台評估

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 357851
出版日期 內容資訊 英文 140 Pages
訂單完成後即時交付
價格
粉末定量噴霧吸入器:醫療設備的開發平台評估 Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 140 Pages
簡介

本報告提供粉末定量噴霧吸入器相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 粉末定量噴霧吸入器概要

第3章 開發中的產品

  • 粉末定量噴霧吸入器 - 開發中產品:各開發階段
  • 粉末定量噴霧吸入器 - 開發中產品:各地區 (國家)
  • 粉末定量噴霧吸入器 - 開發中產品:各法規途徑
  • 粉末定量噴霧吸入器 - 開發中產品:各核准時期 (估計)
  • 粉末定量噴霧吸入器 - 持續中臨床實驗

第4章 粉末定量噴霧吸入器 - 正在開發的開發中產品:各企業

  • 粉末定量噴霧吸入器企業 - 開發中產品:各開發階段
  • 粉末定量噴霧吸入器 - 開發中產品:各開發階段

第5章 粉末定量噴霧吸入器 開發企業與產品概要

  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corporation
  • Advent Pharmaceuticals Pty Ltd
  • Aespira Ltd.
  • AKELA Pharma Inc. (Inactive)
  • Bayer HealthCare AG
  • Bespak Europe Ltd.
  • GlaxoSmithKline Plc
  • Hovione FarmaCiencia SA
  • MannKind Corporation
  • Nanotherapeutics, Inc.
  • Nektar Therapeutics
  • Novartis AG
  • OPKO Health, Inc.
  • Pharmaxis Limited
  • Respira Therapeutics, Inc.
  • Sandoz International GmbH
  • Sheffield Hallam University
  • 新日本科學
  • Teva Pharmaceutical Industries Ltd.
  • University of Kansas
  • University of Texas Medical Branch at Galveston

第6章 粉末定量噴霧吸入器 - 近幾年趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1016EPD

GlobalData's Medical Devices sector report, "Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Dry Powder Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dry Powder Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Dry Powder Inhaler Devices Overview

3 Products under Development

  • 3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
  • 3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
  • 3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
  • 3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
  • 3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials

4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies

  • 4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development

5 Dry Powder Inhaler Devices Companies and Product Overview

  • 5.1 Adamis Pharmaceuticals Corp Company Overview
    • 5.1.1 Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Advent Pharmaceuticals Pty Ltd Company Overview
    • 5.2.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Aespira Ltd. Company Overview
    • 5.3.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 AKELA Pharma Inc. (Inactive) Company Overview
    • 5.4.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 AstraZeneca Plc Company Overview
    • 5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Bayer AG Company Overview
    • 5.6.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Boehringer Ingelheim International GmbH Company Overview
    • 5.7.1 Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Circassia Group Plc Company Overview
    • 5.8.1 Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Creare LLC Company Overview
    • 5.9.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Eli Lilly and Co Company Overview
    • 5.10.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 GlaxoSmithKline Plc Company Overview
    • 5.11.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Hovione Technology Ltd Company Overview
    • 5.12.1 Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Iconovo AB Company Overview
    • 5.13.1 Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Liquidia Technologies Inc Company Overview
    • 5.14.1 Liquidia Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Lupin Pharmaceuticals Inc Company Overview
    • 5.15.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 MannKind Corp Company Overview
    • 5.16.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Monash University Company Overview
    • 5.17.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Nektar Therapeutics Company Overview
    • 5.18.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Ology Bioservices Inc Company Overview
    • 5.19.1 Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 OPKO Health Inc Company Overview
    • 5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 OtiTopic LLC Company Overview
    • 5.21.1 OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Pharmaxis Ltd Company Overview
    • 5.22.1 Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Quench Medical Inc Company Overview
    • 5.23.1 Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Respira Therapeutics Inc Company Overview
    • 5.24.1 Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Sandoz International GmbH Company Overview
    • 5.25.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Sheffield Hallam University Company Overview
    • 5.26.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Spyryx Biosciences Inc Company Overview
    • 5.27.1 Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Sun Pharma Advanced Research Company Ltd Company Overview
    • 5.28.1 Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 University of Kansas Company Overview
    • 5.29.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 University of Sydney Company Overview
    • 5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 University of Texas Medical Branch at Galveston Company Overview
    • 5.31.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Vectura Group Plc Company Overview
    • 5.32.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 Verona Pharma Plc Company Overview
    • 5.33.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Virginia Commonwealth University Company Overview
    • 5.34.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

6 Dry Powder Inhaler Devices- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
  • Table 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
  • Table 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
  • Table 4: Dry Pow

List of Figures

List of Figures

  • Figure 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
  • Figure 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
  • Figure 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
  • Figure 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials